News

The study evaluated the effect of a single application of NGX-4010, the company’s novel dermal patch, on pain due to postherpetic neuralgia (PHN). The primary endpoint in this

The top-line results from the trial comparing Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C with Pegasys suggest that Albuferon may offer

Aspreva is currently evaluating CellCept, known generically as mycophenolate mofetil, for the treatment of lupus nephritis in a global phase III study. The FDA’s fast track designation is

As a result of the positive findings, Sangamo expects to initiate a phase I clinical trial to test the HIV ZFP therapy in the second half of 2007.

“By giving the CHF guidance more prominence in the Actos label, we hope to ensure that this information is being attended to by treating physicians to optimize patient

Roche revealed that it is carrying out the recall in agreement and cooperation with the EMEA and Swissmedic health authorities, after receiving several reports that some batches of

The data supporting the NDA showed doripenem was an effective treatment for hospital-acquired, or nosocomial, pneumonia. The data also demonstrated the effectiveness of doripenem against infections caused by

The study is expected to enroll approximately 200 patients at 35 leading multiple sclerosis (MS) clinical centers in the US and Canada. Fifteen centers have been initiated and

The trial evaluated the safety, tolerability and antiviral activity of single and multiple doses of the drug, XTL-2125, with 56 patients. Although XTL-2125 was generally well tolerated, the